Screener
Polaryx Therapeutics, Inc. PLYX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Polaryx Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The source filing: Polaryx Therapeutics, Inc.’s 10-Q, filed May 15, 2026. Open the filing →
- Filed
- May 14, 2026, 8:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-056973
FAQ
- What is Polaryx Therapeutics, Inc.'s net change in cash?
- Polaryx Therapeutics, Inc. (PLYX) reported net change in cash of -206,300,000% in Q1 2026.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Polaryx Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude